de Reijke T - Search Results

1

External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcome.

Auprich M, Haese A, Walz J, Pummer K, de la Taille A, Graefen M, de Reijke T, Fisch M, Kil P, Gontero P, Irani J, Chun FK. Auprich M, et al. Among authors: de la taille a, de reijke t. Eur Urol. 2010 Nov;58(5):727-32. doi: 10.1016/j.eururo.2010.06.038. Epub 2010 Jul 3. Eur Urol. 2010. PMID: 20619529

2

Does prostate-specific antigen density alter decision making on biopsy?

Vleeming R, de Craen AJ, de Reijke TM, van Andel G, Kurth KH. Vleeming R, et al. Among authors: de craen aj, de reijke tm. Eur Urol. 1996;29(1):10-14. doi: 10.1159/000473710. Eur Urol. 1996. PMID: 8821683

3

Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer.

Van der Poel HG, Van Balken MR, Schamhart DH, Peelen P, de Reijke T, Debruyne FM, Schalken JA, Witjes JA. Van der Poel HG, et al. Among authors: de reijke t. Urology. 1998 Jan;51(1):44-50. doi: 10.1016/s0090-4295(97)00496-2. Urology. 1998. PMID: 9457287

4

Considerations regarding prostate biopsies.

Beerlage HP, de Reijke TM, de la Rosette JJ. Beerlage HP, et al. Among authors: de reijke tm, de la rosette jj. Eur Urol. 1998 Oct;34(4):303-12. doi: 10.1159/000019746. Eur Urol. 1998. PMID: 9748677 Review.

5

Urinary interleukin-2 monitoring during prolonged bacillus Calmette-Guerin treatment: can it predict the optimal number of instillations?

de Reijke TM, De Boer EC, Kurth KH, Schamhart DH. de Reijke TM, et al. Among authors: de boer ec. J Urol. 1999 Jan;161(1):67-71. doi: 10.1097/00005392-199901000-00024. J Urol. 1999. PMID: 10037371 Clinical Trial.

6

Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the EORTC Phase-III trial 30893.

Fosså SD, Curran D, Aaronson NK, Keuppens F, Kliment J, Robinson MR, DeReijke TM, Hetherington J, Kil PJ, Rea LA. Fosså SD, et al. Eur Urol. 2000 May;37(5):541-51. doi: 10.1159/000020191. Eur Urol. 2000. PMID: 10765092 Clinical Trial.

7

Transrectal ultrasound in the diagnosis of prostate cancer: state of the art and perspectives.

Sedelaar JP, Vijverberg PL, De Reijke TM, de la Rosette JJ, Kil PJ, Braeckman JG, Hendrikx AJ. Sedelaar JP, et al. Among authors: de reijke tm, de la rosette jj. Eur Urol. 2001 Sep;40(3):275-84. doi: 10.1159/000049787. Eur Urol. 2001. PMID: 11684843 Review.

8

Intermittent maximal androgen blockade in patients with metastatic prostate cancer: an EORTC feasibility study.

Albrecht W, Collette L, Fava C, Kariakine OB, Whelan P, Studer UE, De Reijke TM, Kil PJ, Rea LA. Albrecht W, et al. Eur Urol. 2003 Nov;44(5):505-11. doi: 10.1016/s0302-2838(03)00375-0. Eur Urol. 2003. PMID: 14572746

9

Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891).

Studer UE, Collette L, Whelan P, Albrecht W, Casselman J, de Reijke T, Knönagel H, Loidl W, Isorna S, Sundaram SK, Debois M; EORTC Genitourinary Group. Studer UE, et al. Among authors: de reijke t. Eur Urol. 2008 May;53(5):941-9. doi: 10.1016/j.eururo.2007.12.032. Epub 2007 Dec 27. Eur Urol. 2008. PMID: 18191322 Clinical Trial.

10

Optimizing prostate cancer detection: 8 versus 12-core biopsy protocol.

de la Rosette JJ, Wink MH, Mamoulakis C, Wondergem N, ten Kate FJ, Zwinderman K, de Reijke TM, Wijkstra H. de la Rosette JJ, et al. J Urol. 2009 Oct;182(4):1329-36. doi: 10.1016/j.juro.2009.06.037. Epub 2009 Aug 15. J Urol. 2009. PMID: 19683269 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters